Clinical Trial Update: Safety Study of Combined Chemotherapy and Endostar to Untreated Patients With Advanced Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 safety study evaluating the combination of chemotherapy and Endostar in untreated patients with advanced melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Endostar (recombinant human endostatin)

Snippet

Sponsor: Simcere Pharmaceutical Co., Ltd | Conditions: Advanced Melanoma, Untreated Patients | Phase 2 | Status: UNKNOWN